Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Characterizing Clinical and Pharmacological Neuroimaging Biomarkers

To see complete record on, please visit this link

Id: NCT03842800

Organisation Name: Yale University

Overal Status: Completed

Start Date: April 1, 2013

Last Update: July 1, 2020

Lead Sponsor: Yale University

Brief Summary: This study is part of a larger overall study that seeks to characterize clinical and pharmacological neuroimaging biomarkers. The purpose of this registered protocol is understand the effect of emotion on cognitions by specifically examining the effect of reward processing on working memory in patients with schizophrenia.

  • Cognitive Impairment

Total execution time in seconds: 0.37853598594666